Biosimilars: Expanding Options for Cancer Care

Biosimilars are increasing the number of safe, effective treatments for cancer. How can policies ensure that they’re accessible for oncologists to personalize cancer care?

Join AfPA

Ready to advance patient-centered care?

Quick Links

Connect

Subscribe

Get the latest health policy insights directly in your inbox

By subscribing, you agree to our privacy policy and consent to receive updates about patient access advocacy.